Inhibition of pp60(c-src) protein kinase by herbimycin A in polyomavirus middle tumor antigen-transformed cells

Anticancer Research

Volumn 17, Issue 5 A, 1997, Pages 3273-3279

  Yang, Ya Wun ^a,b,c   Chang, Yea Hueay ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Herbimycin A; Polyomavirus; Src protein kinase

Indexed keywords

HERBIMYCIN A; PROTEIN KINASE; VIRUS MIDDLE T ANTIGEN; ANTINEOPLASTIC ANTIBIOTIC; BENZOQUINONE DERIVATIVE; ENZYME INHIBITOR; HERBIMYCIN; MACROCYCLIC LACTAM; PROTEIN KINASE P60; QUINONE DERIVATIVE; VIRUS T ANTIGEN;

ANIMAL CELL; ARTICLE; ENZYME ACTIVITY; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; POLYOMA VIRUS; PRIORITY JOURNAL; VIRUS CARCINOGENESIS; VIRUS CELL TRANSFORMATION; ANIMAL; CELL DIVISION; CELL STRAIN 3T3; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM;

3T3 CELLS; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTIGENS, POLYOMAVIRUS TRANSFORMING; BENZOQUINONES; CELL DIVISION; CELL TRANSFORMATION, VIRAL; ENZYME INHIBITORS; LACTAMS, MACROCYCLIC; MICE; PROTO-ONCOGENE PROTEINS PP60(C-SRC); QUINONES;

EID: 0030609021     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Treisman R, Novak U, Favaloro J, Kamen R: Transformation of rat cells by an altered polyoma virus genome expressing only the middle-T protein. Nature 292: 595-600, 1981.
2. Rassoulzadegan M, Cowie A, Carr A, Glaichenhaus N, Kamen R, Cuzin F: The roles of individual polyoma virus early proteins in oncogenic transformation. Nature 300: 713-718, 1982.
3. Courtneidge SA, Smith AE: Polyomavirus transforming protein associates with the product of the c-src cellular gene. Nature 303: 435-439, 1983.
4. c-src is required for cell transformation. EMBO J 5: 325-334, 1986.
5. Bolen JB, Thiele CJ, Israel MA, Yonemoto W, Lipsich LA, Brugge JS: Enhancement of cellular src gene product associated tyrosyl kinase activity following polyomavirus infection and transformation. Cell 38: 767-777, 1984.
6. c-src associated with polyomavirus middle tumor antigen. Mol Cell Biol 6: 1562-1570, 1986.
7. Markland W, Smith AE: Mutants of polyomavirus middle-T antigen. Biochim Biophy Acta 907: 299-321, 1987.
8. c-src. J Virol 53: 114-119, 1985.
9. c-src tyrosyl kinase activity in human neuroblastomas is associated with polyoma middle tumor antigen synthesis. J Cell Biochem 27: 157-167, 1985.
10. Uehara Y, Hori M, Takeuchi T, Umezawa H: Screening of agents which convert 'transformed morphology' of Rous sarcoma virus-infected rat kidney cells to 'normal morphology': Identification of an active agent as herbimycin and its inhibition of intracellular src kinase. Jpn. J Cancer Res 76: 672-675, 1985.
11. src in rat kidney cells infected with Rous sarcoma virus. Mol Cell Biol 6: 2198-2206, 1986.
12. Murakami Y, Mizuno S, Hori M, Uehara Y: Reversal of transformed phenotypes by herbimycin A in src oncogene expressed rat fibroblast. Cancer Res 48: 1587-1590, 1988.
13. v-src. Cancer Res 49: 780-785, 1989.
14. v-src with the cytoskeletal structure and with phosphatidylinositol 3 kinase. Oncogene 8: 559-564, 1993.
15. Dilworth SM, Griffin BE: Monoclonal antibodies against polyoma virus tumor antigens. Proc Natl Acad Sci USA 79: 1059-1063, 1982.
16. Benjamin TL: Host range mutants of polyoma virus. Proc Natl Acad Sci USA 67: 394-399, 1970.
17. c-src kinase activity in polyoma virus MT antigen transformed cells. Anticancer Res 14: 2529-2536, 1994.
18. Benjamin TL: Methods of cell transformation by tumor viruses. In: Methods in Cell Biology, Vol. VIII. New York, Academic Press, Inc., 1974, pp 367-437.
19. c-src expression in rat and mouse fibroblasts by an inducible antisense gene: effects on serum regulation of growth and polyoma virus middle T function. Cell Growth and Differ 2: 51-58, 1991.
20. c-src EMBO J. 3: 585-591, 1984.
21. c-src kinase by middle T antigen binding or by dephosphorylation. EMBO J 4: 1471-1477, 1985.
22. Uehara Y, Murakami Y, Mizuno S, Kawai S: Inhibition of transforming activity of tyrosine kinase oncogenes by herbimycin A. Virology 164: 294-298, 1988.
23. Fukazawa H, Li P-M, Yamamoto CY, Murakami Y, Mizuno S, Uehara Y: Specific inhibition of cytoplasmic protein tyrosine kinases by herbimycin A in vitro. Biochem Pharmacol 42: 1661-1667, 1991.
24. Uehara Y, Fukazawa H: Use and selectivity of herbimycin A as inhibitor of protein-tyrosine kinases. Method Enzymol 201: 370-379, 1991.
25. 14C]herbimycin A and its use in the elucidation of the kinase inactivation mechanism. FEBS Lett 340: 155-158, 1994.